Works by Silas, Peter E.

Results: 2
    1

    Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study.

    Published in:
    Journal of the Pediatric Infectious Diseases Society, 2020, v. 9, n. 2, p. 194, doi. 10.1093/jpids/piz010
    By:
    • Klein, Nicola P;
    • Abu-Elyazeed, Remon;
    • Povey, Michael;
    • Parra, Mercedes Macias;
    • Diez-Domingo, Javier;
    • Ahonen, Anitta;
    • Korhonen, Tiina;
    • Tinoco, Juan-Carlos;
    • Weiner, Leonard;
    • Marshall, Gary S;
    • Silas, Peter E;
    • Sarpong, Kwabena O;
    • Ramsey, Keith P;
    • Fling, John A;
    • Speicher, David;
    • Campos, Maribel;
    • Munjal, Iona;
    • Peltier, Christopher;
    • Vesikari, Timo;
    • Baccarini, Carmen
    Publication type:
    Article
    2

    A double-blind, randomized, multicenter, controlled study to evaluate the immunogenicity, safety, and tolerability of varicella vaccine (VARIVAX™) passage extension 34 (PE34) process administered concomitantly with measles, mumps, and rubella vaccine (M-M-R™ II)

    Published in:
    Human Vaccines & Immunotherapeutics, 2020, v. 16, n. 11, p. 2634, doi. 10.1080/21645515.2020.1743122
    By:
    • Silas, Peter E.;
    • Zissman, Edward N.;
    • Gardner, Julie;
    • Helian, Shanjun;
    • Lee, Andrew W.;
    • Platt, Heather L.
    Publication type:
    Article